Volume 28, Issue 3 (Iran South Med J 2025)                   Iran South Med J 2025, 28(3): 666-674 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Habibi Daronkolayi K, Eslami Moayed M, Enayatrad M, Talebi A. Serum Vitamin D Levels and Their Association with Anti-Müllerian Hormone in Infertile Women. Iran South Med J 2025; 28 (3) :666-674
URL: http://ismj.bpums.ac.ir/article-1-2341-en.html
1- Student Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran
2- Sexual Health and Fertility Research Center, Shahroud University of Medical Sciences, Shahroud, Iran
3- Clinical Research Development Unit, Bahar Hospital, Shahroud University of Medical Sciences, Shahroud, Iran
4- Sexual Health and Fertility Research Center, Shahroud University of Medical Sciences, Shahroud, Iran , alitalebi.ir@gmail.com
Abstract:   (198 Views)
Background: Anti-Müllerian hormone (AMH) is one of the most important biomarkers produced by granulosa cells and is measured as an indicator of ovarian reserve. Due to the contradictory findings of previous studies, the present study aimed to evaluate the serum concentration of vitamin D in a population of infertile women and its relationship with serum AMH levels.
Materials and Methods: The study population included infertile women who had undergone their treatment at the Shokoofeh Infertility Treatment Center in Shahroud. By reviewing patient medical records, serum levels of vitamin D and AMH were extracted from previous laboratory data. To assess the correlation between vitamin D and AMH levels in the study population, a regression analysis was performed in SPSS software (version 28).
Results: Among the infertile women examined, 37.2% (n=55) had vitamin D deficiency, while 62.8% (n=63) had normal vitamin D levels. The mean AMH level did not differ significantly between the two groups (normal vs. abnormal vitamin D). The overall mean AMH concentration was 1.9 ng/mL (±1.1). In the group with normal vitamin D levels, the mean AMH was 1.8 ±1.1 ng/mL, whereas in the group with abnormal vitamin D levels it was 1.9±1.2 ng/mL (p=0.396). No significant correlation was observed between vitamin D and AMH levels (p=0.120, Spearman’s r=0.017).
Conclusion: The findings of the present study align with those studies that have reported no association between vitamin D and AMH levels. Given the involvement of various factors in gene expression, it is possible that, despite vitamin D being considered a regulatory candidate, other factors may play a more influential role than vitamin D in regulating AMH expression.
Full-Text [PDF 439 kb]   (181 Downloads)    
Type of Study: Original | Subject: Gynecology
Received: 2025/09/9 | Accepted: 2025/11/25 | Published: 2025/12/27

References
1. Arce J-C, La Marca A, Klein BM, et al. Antimülleri-an hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients. Fertil Steril 2013; 99(6): 1644-53. [DOI]
2. de Marcillac FD, Pinton A, Guillaume A, et al. What are the likely IVF/ICSI outcomes if there is a discrepancy between serum AMH and FSH levels? A multicenter retrospective study. J Gynecol Obstet Hum Reprod 2017; 46(8): 629-35. [DOI]
3. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357(3): 266-81. [DOI]
4. Kassi E, Adamopoulos C, Basdra EK, et al. Role of vitamin D in atherosclerosis. Circulation 2013; 128(23): 2517-31. [DOI]
5. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311(5768): 1770-3. [DOI]
6. Zarnani AH, Shahbazi M, Salek-Moghaddam A, et al. Vitamin D3 receptor is expressed in the endometrium of cycling mice throughout the estrous cycle. Fertil Steril 2010; 93(8): 2738-43. [DOI]
7. Shahbazi M, Jeddi-Tehrani M, Zareie M, et al. Expression profiling of vitamin D receptor in placenta, decidua and ovary of pregnant mice. Placenta 2011; 32(9): 657-64. [DOI]
8. Grzeczka A, Graczyk S, Skowronska A, et al. Relevance of vitamin D and its deficiency for the ovarian follicle and the oocyte: an update. Nutrients 2022; 14(18): 3712. [DOI]
9. Xu F, Wolf S, Xu J. Vitamin D in follicular development and oocyte maturation. Reproduction 2021; 161(6): R129-R137. [DOI]
10. Chu J, Gallos I, Tobias A, et al. Vitamin D and assisted reproductive treatment outcome: a systematic review and meta-analysis. Hum Reprod 2018; 33(1): 65-80. [DOI]
11. Cozzolino M, Busnelli A, Pellegrini L, et al. How vitamin D level influences in vitro fertilization outcomes: results of a systematic review and meta-analysis. Fertil Steril 2020; 114(5): 1014-25. [DOI]
12. Ko JK, Shi J, Li RH, et al. 100 YEARS OF VITAMIN D: Effect of serum vitamin D level before ovarian stimulation on the cumulative live birth rate of women undergoing in vitro fertilization: a retrospective analysis. Endocr Connect 2022; 11(2): e210444. [DOI]
13. Chen Y, Zhi X. Roles of vitamin D in reproductive systems and assisted reproductive technology. Endocrinology 2020; 161(4): bqaa023. [DOI]
14. Amrein K, Scherkl M, Hoffmann M, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr 2020; 74(11): 1498-513. [DOI]
15. Moolhuijsen LME, Visser JA. AntiMüllerian Hor-mone and Ovarian Reserve: Update on Assessing Ovarian Function. J Clin Endocrinol Metab 2020; 105(11): 3361-73. [DOI]
16. Várbíró S, Takács I, Tűű L, et al. Effects of Vitamin D on fertility, pregnancy and polycystic ovary syndrome—a review. Nutrients 2022; 14(8): 1649. [DOI]
17. Yoshizawa T, Handa Y, Uematsu Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997; 16(4): 391-6. [DOI]
18. Parikh G, Varadinova M, Suwandhi P, et al. Vitamin D regulates steroidogenesis and IGFBP-1 production in human ovarian cells. Horm Metab Res 2010; 42(10): 754-7. [DOI]
19. Irani M, Seifer D, Minkoff H, et al. Vitamin D supplementation appears to normalize serum AMH levels in vitamin D deficient premenopausal women. Fertil Steril 2013; 100(3): S338. [DOI]
20. Aramesh S, Alifarja T, Jannesar R, et al. Does vitamin D supplementation improve ovarian reserve in women with diminished ovarian reserve and vitamin D deficiency: a before-and-after intervention study. BMC Endocr Disord 2021; 21(1): 126. [DOI]
21. Halder S, Ishrat S, Rahman F, et al. Vitamin D supplementation in women with diminished ovarian reserve: a randomized controlled trial. Int J Reprod Contracept Obstet Gynecol 2021; 11(10): 2. [DOI]
22. Karimi E, Arab A, Rafiee M, et al. A systematic review and meta-analysis of the association between vitamin D and ovarian reserve. Sci Rep 2021; 11(1): 16005. [DOI]
23. Moridi I, Chen A, Tal O, et al. The association be-tween vitamin D and anti-müllerian hormone: A systematic review and meta-analysis. Nutrients 2020; 12(6): 1567. [DOI]
24. Lata I, Tiwari S, Gupta A, et al. To Study the Vitamin D Levels in Infertile Females and Correlation of Vitamin D Deficiency with AMH Levels in Comparison to Fertile Females. J Hum Reprod Sci 2017; 10(2): 86-90. [DOI]
25. Wong HYQ, Li HWR, Lam KSL, et al. Independent association of serum vitamin D with anti-Mullerian hormone levels in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2018; 89(5): 634-41. [DOI]
26. Rogenhofer N, Jeschke U, von Schönfeldt V, et al. Seasonal dynamic of cholecalciferol (D3) and anti-Muellerian hormone (AMH) with impact on ovarian response and IVF/ICSI. Arch Gynecol Obstet 2022; 306(1): 219-28. [DOI]
27. Rogenhofer N, Mischitz D, Mann C, et al. Correla-tion of Vitamin D3 (Calcitriol) Serum Concentrations with Vitamin B12 and Folic Acid in Women Undergoing in vitro Fertilisation/Intracytoplasmatic Sperm Injection. Gynecol Obstet Invest 2019; 84(2): 128-35. [DOI]
28. Kim S, Kim JJ, Kim M-J, et al. Relationship be-tween serum anti-Mullerian hormone with vitamin D and metabolic syndrome risk factors in late reproductive-age women. Gynecol Endocrinol 2018; 34(4): 327-31. [DOI]
29. Mu Y, Cheng D, Yin T l, et al. Vitamin D and Polycystic Ovary Syndrome: a Narrative Review. Reprod Sci 2021; 28(8): 2110-7. [DOI]
30. Kalaitzopoulos DR, Samartzis N, Daniilidis A, et al. Effects of vitamin D supplementation in endometriosis: a systematic review. Reprod Biol Endocrinol 2022; 20(1): 176. [DOI]
31. Meng X, Zhang J, Wan Q, et al. Influence of Vita-min D supplementation on reproductive outcomes of infertile patients: a systematic review and meta-analysis. Reprod Biol Endocrinol 2023; 21(1): 17. [DOI]
32. Simpson S, Pal L. Vitamin D and infertility. Curr Opin Obstet Gynecol 2023; 35(4): 300-5. [DOI]
33. Ghasemi A, Doroudian Z, Barekat M, et al. The Correlation of the Follicular Fluid Levels of Anti-Mullerian Hormone and Beta Human Chorionic Gonadotropin with Oocyte Maturation. Iran South Med J 2019; 22(5): 296-306. (Persian) [DOI]

Send email to the article author


Rights and Permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Iranian South Medical Journal

Designed & Developed by: Yektaweb